ASX:CSL 4 January 2026 - 30 January 2026

CSL Ltd shares slipped 0.33% on Wednesday, closing at A$176.11. The drop trimmed gains made since early January lows as investors balanced renewed broker backing against ongoing volatility in risk assets. With a market cap near A$85 billion, CSL’s stock still trades well under last year’s highs.

CSL Limited shares closed Monday 0.55% higher at A$176.50, boosted by a broker upgrade that helped the healthcare giant resist broader market weakness. Despite the lift, the stock remains roughly 36% below its level from a year ago.

CSL Limited shares ended Friday 0.14% higher, closing at A$175.53. The stock fluctuated between A$174.35 and A$176.03 during the session, with roughly 1.07 million shares traded. The S&P/ASX 200 finished the day up 0.48%, settling at 8,903.90.

CSL Ltd closed Wednesday just 0.1% higher at A$173.49, after swinging between A$172.14 and A$174.69 during the session. Trading volume hit roughly 1.11 million shares. The stock has dropped roughly 37% over the last year, lingering just above its 52-week low of A$168.

CSL Limited shares slipped 0.09% to close at A$174.29 on Friday, following a 2.62% gain the previous day. This month, the stock has fluctuated between A$168.29 and A$175.60.